Mutations identified in childhood brain cancer
Richard K. Wilson, PhD, and colleagues have identified mutations responsible for the most common type of childhood brain cancer and shown that the tumors are susceptible to drugs already in development.
Potential drug targets identified in common childhood brain cancer
Researchers studying the genetic roots of the most common malignant childhood brain tumor have discovered missteps in three of the four subtypes of the cancer involving genes that are already being targeted for drug development.
World’s largest hunk of cancer genome data released
St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project has announced the largest release to date of comprehensive human cancer genome data for free access by the global scientific community.